Articles by Kaylynn Chiarello-Ebner - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Kaylynn Chiarello-Ebner

Kaylynn Chiarello-Ebner

Kaylynn Chiarello-Ebner is a former managing editor of Pharmaceutical Technology.

Justifying the Means
February 2, 2007

When it comes to ethics, the adage "hindsight is 20/20" is especially applicable. Countless medical and psychological experiments—such as the 1932 Tuskegee syphilis study or Zimbardo's 1972 Stanford mock-prison experiment—were conducted in the name of science and are now plainly recognized as enormous violations of ethical and human rights.

FDA Creates Office of the Chief Medical Officer, Announces Staff Changes
January 25, 2007

The US Food and Drug Administration announced the creation of the Office of the Chief Medical Officer as well as two important staff changes at the agency.

New Strategies for the CRO–Sponsor Relationship
January 2, 2007

The evolving contract research organization–sponsor relationship has initiated a state of transition for contract analytical laboratories.

Caution When Traveling Full Speed Ahead
January 2, 2007

The closing presentation was perfectly pitched to bring a lump to our throats and have us cheering for fast-track drug development. I and 30 other journalists had spent the day touring a Big Pharma plant, and now sat shoulder to shoulder in a warm conference room, awaiting the final speaker.

Gottlieb Resigns from FDA
December 15, 2006

Dec. 11, 2006 (Rockville, MD)-Effective Jan. 16, 2007, Scott Gottlieb, MD, deputy commissioner for medical and scientific affairs at the US Food and Drug Administration, will leave the agency and will return to the American Enterprise Institute.

Funding Ripple Effects
December 2, 2006

Poor support of drug- and process-development training programs will affect industry's future growth.

Perrigo Recalls 11 Million Bottles of Acetaminophen
November 16, 2006

Over-the-counter drug maker Perrigo Company issued a voluntary recall of certain lots of store-brand acetaminophen 500-mg caplets that could contain trace amounts of metal particulate. Approximately 11 million bottles of acetaminophen are affected by the recall.

Virtual Product Development Offers Cost Savings
November 3, 2006

San Antonio, TX (Nov. 1)-The opening session of the ?Pharmaceutical Technologies? track at the 2006 Annual Meeting of the American Association of Pharmaceutical Scientists in San Antonio, Texas was standing room only as R. Christian Moreton, PhD, vice-president of pharmaceutical science at Idenix Pharmaceuticals, and Richard O. Mannion of Purdue Pharma discussed ?Product Development Using a Virtual Company Model.?

Contract Services Growth Strong, but Slowing
November 3, 2006

San Antonio, TX (Nov. 1)?Market growth in the pharmaceutical outsourcing industry is strong, but slowing, according to Jim Miller, president of PharmSource Information Services, Inc. and publisher of Bio/Pharmaceutical Outsourcing Report.


LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
FindPharma Custom Search
Click here